740 related articles for article (PubMed ID: 10084743)
1. Clinical relevance of in vitro propagation of activated lymphocytes from endomyocardial biopsy samples of pediatric heart transplant recipients.
Webber SA; Bentlejewski C; Park A; Fricker FJ; Griffith C; Boyle GJ; Miller SA; Pham S; Murali S; Griffith BP; Duquesnoy R; Zeevi A
Pediatr Transplant; 1998 Aug; 2(3):200-5. PubMed ID: 10084743
[TBL] [Abstract][Full Text] [Related]
2. Additive value of immunologic monitoring to histologic grading of heart allograft biopsy specimens: implications for therapy.
Fisher PE; Suciu-Foca N; Ho E; Michler RE; Rose EA; Mancini D
J Heart Lung Transplant; 1995; 14(6 Pt 1):1156-61. PubMed ID: 8719463
[TBL] [Abstract][Full Text] [Related]
3. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
Herzberg GZ; Rossi AF; Courtney M; Gelb BD
J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
[TBL] [Abstract][Full Text] [Related]
4. Utility of surveillance biopsies in infant heart transplant recipients.
Balzer DT; Moorhead S; Saffitz JE; Huddleston CB; Spray TL; Canter CE
J Heart Lung Transplant; 1995; 14(6 Pt 1):1095-101. PubMed ID: 8719456
[TBL] [Abstract][Full Text] [Related]
5. Propagation of activated T lymphocytes from endomyocardial biopsy samples of cardiac allografts: influence of the addition of recombinant interleukin-4 to the culture environment.
Webber SA; Bentlejewski C; Boyle GJ; Miller SA; Law Y; Murali S; Pham S; Park A; Griffith BP; Duquesnoy R; Zeevi A
Pediatr Transplant; 2002 Apr; 6(2):119-23. PubMed ID: 12000466
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis, surveillance, and epidemiologic evaluation of viral infections in pediatric cardiac transplant recipients with the use of the polymerase chain reaction.
Schowengerdt KO; Ni J; Denfield SW; Gajarski RJ; Radovancevic B; Frazier HO; Demmler GJ; Kearney D; Bricker JT; Towbin JA
J Heart Lung Transplant; 1996 Feb; 15(2):111-23. PubMed ID: 8672514
[TBL] [Abstract][Full Text] [Related]
7. An immunological algorithm to predict risk of high-grade rejection in cardiac transplant recipients.
Itescu S; Tung TC; Burke EM; Weinberg AD; Mancini D; Michler RE; Suciu-Foca NM; Rose EA
Lancet; 1998 Jul; 352(9124):263-70. PubMed ID: 9690405
[TBL] [Abstract][Full Text] [Related]
8. Unsuspected rejection episodes on routine surveillance endomyocardial biopsy post-heart transplant in paediatric patients.
Dixon V; Macauley C; Burch M; Sebire NJ
Pediatr Transplant; 2007 May; 11(3):286-90. PubMed ID: 17430484
[TBL] [Abstract][Full Text] [Related]
9. Routine surveillance myocardial biopsies are unnecessary beyond one year after heart transplantation.
White JA; Guiraudon C; Pflugfelder PW; Kostuk WJ
J Heart Lung Transplant; 1995; 14(6 Pt 1):1052-6. PubMed ID: 8719450
[TBL] [Abstract][Full Text] [Related]
10. Different patterns in donor-specific production of T-helper 1 and 2 cytokines by cells infiltrating the rejecting cardiac allograft.
van Besouw NM; Daane CR; Vaessen LM; Balk AH; Claas FH; Zondervan PE; Jutte NH; Weimar W
J Heart Lung Transplant; 1995; 14(5):816-23. PubMed ID: 8800715
[TBL] [Abstract][Full Text] [Related]
11. [Pathology of heart transplantation.(Morphological study of 1246 endomyocardial biopsies from 167 transplanted hearts). Causes of early, intermediate, and late deaths].
Agozzino L; Thomopoulos K; Esposito S; Agozzino M; De Vivo F; Maiello C; Cotrufo M
Pathologica; 1999 Apr; 91(2):89-100. PubMed ID: 10484868
[TBL] [Abstract][Full Text] [Related]
12. Expression of early and late activation markers on peripheral blood T lymphocytes does not reliably reflect immune events in transplanted hearts.
Loertscher R; Forbes RD; Halabi G; Lavery P; Quinn T
Clin Transplant; 1994 Jun; 8(3 Pt 1):230-8. PubMed ID: 8061361
[TBL] [Abstract][Full Text] [Related]
13. Endomyocardial biopsy in pediatric heart transplant recipients: a useful exercise? (Analysis of 1,169 biopsies).
Wagner K; Oliver MC; Boyle GJ; Miller SA; Law YM; Pigula F; Webber SA
Pediatr Transplant; 2000 Aug; 4(3):186-92. PubMed ID: 10933318
[TBL] [Abstract][Full Text] [Related]
14. Creatine kinase MB isoforms: a potential predictor of acute cardiac allograft rejection.
Anderson JR; Hossein-Nia M; Brown PA; Corbishley C; Murday AJ; Holt DW
J Heart Lung Transplant; 1995; 14(4):666-70. PubMed ID: 7578173
[TBL] [Abstract][Full Text] [Related]
15. Preferential endocardial residence of B-cells in the "Quilty effect" of human heart allografts: immunohistochemical distinction from rejection.
Radio SJ; McManus BM; Winters GL; Kendall TJ; Wilson JE; Costanzo-Nordin MR; Ye YL
Mod Pathol; 1991 Sep; 4(5):654-60. PubMed ID: 1836878
[TBL] [Abstract][Full Text] [Related]
16. Increased myocardial performance index correlates with biopsy-proven rejection in pediatric heart transplant recipients.
Leonard GT; Fricker FJ; Pruett D; Harker K; Williams B; Schowengerdt KO
J Heart Lung Transplant; 2006 Jan; 25(1):61-6. PubMed ID: 16399532
[TBL] [Abstract][Full Text] [Related]
17. Detection of cardiac allograft rejection and response to immunosuppressive therapy with peripheral blood gene expression.
Horwitz PA; Tsai EJ; Putt ME; Gilmore JM; Lepore JJ; Parmacek MS; Kao AC; Desai SS; Goldberg LR; Brozena SC; Jessup ML; Epstein JA; Cappola TP
Circulation; 2004 Dec; 110(25):3815-21. PubMed ID: 15583081
[TBL] [Abstract][Full Text] [Related]
18. Lymphocyte growth from cardiac allograft biopsy specimens with no or minimal cellular infiltrates: association with subsequent rejection episode.
Weber T; Kaufman C; Zeevi A; Zerbe TR; Hardesty RJ; Kormos RH; Griffith BP; Duquesnoy RJ
J Heart Transplant; 1989; 8(3):233-40. PubMed ID: 2661773
[TBL] [Abstract][Full Text] [Related]
19. Intragraft FOXP3 mRNA expression reflects antidonor immune reactivity in cardiac allograft patients.
Dijke IE; Velthuis JH; Caliskan K; Korevaar SS; Maat AP; Zondervan PE; Balk AH; Weimar W; Baan CC
Transplantation; 2007 Jun; 83(11):1477-84. PubMed ID: 17565321
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic characterisation of cellular infiltrates in endomyocardial biopsies of heart transplant recipients with diagnosed steroid resistant cellular rejection.
Zakliczyński M; Zakliczyńska H; Klimczak A; Nozyński J; Kozłowska K; Trzcińska I; Przybylski R; Wojarski J; Durmała J; Lange A; Zembala M
Ann Transplant; 2003; 8(1):13-8. PubMed ID: 12848378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
